M. Altinok

Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.

D. Glintborg, M. Andersen, J. Sidelmann, 2015, Metabolism: clinical and experimental.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

D. Glintborg, J. Henriksen, M. Andersen, 2016, Human reproduction.

Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.

K. Brusgaard, Q. Tan, D. Glintborg, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS

K. Højlund, D. Glintborg, M. Andersen, 2018, Endocrine connections.

Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours

D. Glintborg, P. Ravn, K. Petersen, 2015, BMJ Case Reports.

Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.

A. Hermann, D. Glintborg, M. Andersen, 2014, The Journal of clinical endocrinology and metabolism.

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.

D. Glintborg, M. Andersen, P. Ravn, 2014, Human reproduction.

Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome

B. Richelsen, D. Glintborg, M. Andersen, 2014, Journal of Endocrinological Investigation.

Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

J. Hallas, D. Glintborg, M. Andersen, 2014, Clinical Endocrinology.

Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome

D. Glintborg, M. Andersen, P. Ravn, 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

D. Glintborg, J. Henriksen, M. Andersen, 2016, Human reproduction.